Companies: 10,795·Total market cap: $144.5T
Vaxcyte, Inc.

Vaxcyte, Inc.

PCVXNASDAQHealthcare● Active
$46.61
$-0.75(-1.58%)
Market Cap$6.7B
P/E Ratio
52W High$65
52W Low$29.08

Vaxcyte, Inc. (PCVX) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · PCVX · as of Jun 8, 2026

Activity summary

Buy transactions

0

P-Purchase only

Sell transactions

12

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

BEARISH
↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Vaxcyte, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

PCVX insider buying and selling by quarter

PCVX insider selling · PCVX insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
758K379K0
2025 Q3
2025 Q4
2026 Q1
2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · PCVX ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

PCVX executive sell shares · PCVX board member insider trading · PCVX insider trading SEC filing

Showing 71 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Wassil Jim

CHIEF OPERATING OFFICER

Sale

Date

May 1

Shares

2,250

Price

$56.83

Value

$128K

View Form 4 on SEC.gov

Cowan Elvia

SVP, Finance & CAO

Option

Date

Apr 7

Shares

3,000

Price

$25.92

Value

$78K

View Form 4 on SEC.gov

Cowan Elvia

SVP, Finance & CAO

Sale

Date

Apr 7

Shares

3,000

Price

$60.00

Value

$180K

View Form 4 on SEC.gov

Wassil Jim

CHIEF OPERATING OFFICER

Sale

Date

Apr 1

Shares

1,412

Price

$58.14

Value

$82K

View Form 4 on SEC.gov

Wassil Jim

CHIEF OPERATING OFFICER

Sale

Date

Apr 1

Shares

838

Price

$58.93

Value

$49K

View Form 4 on SEC.gov

Cowan Elvia

SVP, Finance & CAO

Sale

Date

Mar 17

Shares

1,487

Price

$55.39

Value

$82K

View Form 4 on SEC.gov

Cowan Elvia

SVP, Finance & CAO

Sale

Date

Mar 17

Shares

405

Price

$56.26

Value

$23K

View Form 4 on SEC.gov

Dhaliwal Harpreet S.

Chief Technical Ops Officer

Other

Date

Mar 9

Shares

604

Price

$59.32

Value

$36K

View Form 4 on SEC.gov

PICKERING GRANT

CHIEF EXECUTIVE OFFICER · Director

Other

Date

Mar 9

Shares

3,685

Price

$59.32

Value

$219K

View Form 4 on SEC.gov

GUGGENHIME ANDREW

PRESIDENT AND CFO

Other

Date

Mar 9

Shares

1,021

Price

$59.32

Value

$61K

View Form 4 on SEC.gov

Cowan Elvia

SVP, Finance & CAO

Option

Date

Mar 11

Shares

2,500

Price

$25.92

Value

$65K

View Form 4 on SEC.gov

Cowan Elvia

SVP, Finance & CAO

Sale

Date

Mar 11

Shares

2,500

Price

$58.59

Value

$146K

View Form 4 on SEC.gov

Cowan Elvia

SVP, Finance & CAO

Other

Date

Mar 9

Shares

495

Price

$59.32

Value

$29K

View Form 4 on SEC.gov

Wassil Jim

CHIEF OPERATING OFFICER

Other

Date

Mar 9

Shares

975

Price

$59.32

Value

$58K

View Form 4 on SEC.gov

Wassil Jim

CHIEF OPERATING OFFICER

Sale

Date

Mar 10

Shares

2,427

Price

$58.32

Value

$142K

View Form 4 on SEC.gov

Wassil Jim

CHIEF OPERATING OFFICER

Sale

Date

Mar 10

Shares

4,968

Price

$59.16

Value

$294K

View Form 4 on SEC.gov

Cowan Elvia

SVP, Finance & CAO

Option

Date

Feb 26

Shares

7,716

Price

$25.92

Value

$200K

View Form 4 on SEC.gov

Cowan Elvia

SVP, Finance & CAO

Other

Date

Feb 28

Shares

243

Price

$61.98

Value

$15K

View Form 4 on SEC.gov

Cowan Elvia

SVP, Finance & CAO

Other

Date

Mar 2

Shares

326

Price

$61.98

Value

$20K

View Form 4 on SEC.gov

Cowan Elvia

SVP, Finance & CAO

Award

Date

Feb 26

Shares

10,681

Price

Value

View Form 4 on SEC.gov

GUGGENHIME ANDREW

PRESIDENT AND CFO

Award

Date

Feb 26

Shares

44,864

Price

Value

View Form 4 on SEC.gov

GUGGENHIME ANDREW

PRESIDENT AND CFO

Other

Date

Feb 28

Shares

898

Price

$61.98

Value

$56K

View Form 4 on SEC.gov

GUGGENHIME ANDREW

PRESIDENT AND CFO

Other

Date

Mar 2

Shares

1,009

Price

$61.98

Value

$63K

View Form 4 on SEC.gov

PICKERING GRANT

CHIEF EXECUTIVE OFFICER · Director

Award

Date

Feb 26

Shares

105,110

Price

Value

View Form 4 on SEC.gov

PICKERING GRANT

CHIEF EXECUTIVE OFFICER · Director

Other

Date

Feb 28

Shares

2,863

Price

$61.98

Value

$177K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About PCVX insider trading

PCVX insider trades

Vaxcyte, Inc. (PCVX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Cowan Elvia (SVP, Finance & CAO), Wassil Jim (CHIEF OPERATING OFFICER), GUGGENHIME ANDREW (PRESIDENT AND CFO). Over the past 12 months, 5 insiders have filed transactions with the SEC. PCVX insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Vaxcyte, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

PCVX insider trading · 5 questions

The insiders of Vaxcyte, Inc. (PCVX) include executives and directors such as Cowan Elvia (SVP, Finance & CAO), Wassil Jim (CHIEF OPERATING OFFICER), GUGGENHIME ANDREW (PRESIDENT AND CFO), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

PCVX board member insider tradingwho are PCVX insidersPCVX insider rosterVaxcyte, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026